1,395
Views
6
CrossRef citations to date
0
Altmetric
Editorial

A primer on the treatment of schizophrenia through repetitive transcranial magnetic stimulation

&
Pages 1079-1082 | Published online: 09 Jan 2014
 

Financial & competing interests disclosure

In the last 5 years, ZJ Daskalakis received external funding through Brainsway Inc. and a travel allowance through Pfizer and Merck. ZJ Daskalakis has also received speaker funding through Sepracor Inc. and AstraZeneca, and has served on the advisory board for Hoffmann-La Roche Ltd. This work was supported by the Ontario Mental Health Foundation, the Canadian Institutes of Health Research, the Brain and Behaviour Research Foundation, the Temerty Family, the Grant Family, the Centre for Addiction and Mental Health Foundation and the Campbell Institute. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript.

No writing assistance was utilized in the production of this manuscript.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.